CLLAF SCORE-A New Risk Score for Predicting Atrial Fibrillation in Treatment-Naive CLL Patients Initiating First- and Second-Generation BTK Inhibitor Therapy.

Patients who started on ibrutinib had a higher risk to develop AF in comparison to acalabrutinib, although the difference was marginally statistically significant in a univariant model ( p ‐value = 0.073 as reported in Table 1 ).

also in 358 other papers